A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia
Status:
Completed
Trial end date:
2018-03-06
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess analgesic efficacy of ASP8062 relative to placebo as
well as the safety and tolerability. This study also assessed the treatment differences in
physical function as well the improvements in overall subject status (e.g., fibromyalgia
symptoms, global functioning) of ASP8062 relative to placebo.